Article Details
Retrieved on: 2021-08-26 07:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Meanwhile AstraZeneca PLC has added 0.22%. The pharmaceutical company said its Forxiga product had been approved in Japan for the treatment of chronic ...
Article found on: www.proactiveinvestors.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here